HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGG CONTROLS - INVIMA Registration ea223ec280928a7326a9cfd31d7a5137

Access comprehensive regulatory information for HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGG CONTROLS (HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGG CONTROLS) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID ea223ec280928a7326a9cfd31d7a5137 and manufactured by WERFEN COLOMBIA SAS. The device was registered on September 16, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.